Salmeterol Inhalation Powder Administered as the Xinafoate Salt From Hard Polyethylene Capsules Via the HandiHaler® 2, and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE2CompletedINTERVENTIONAL

Enrollment

136

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

February 28, 2006

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Salmeterol medium dose

DRUG

Salmeterol low dose

DRUG

Salmeterol high dose

DRUG

Serevent® Diskus®

DRUG

Placebo HandiHaler®

DRUG

Placebo Diskus®